FDA Panel Endorses Moderna’s Coronavirus Vaccine, Clearing Way For Approval Later This Week
The Hill: FDA endorses safety and efficacy of Moderna’s COVID-19 vaccine
“A coronavirus vaccine manufactured by Moderna is on the verge of authorization after Food and Drug Administration (FDA) scientists found it to be safe and 94 percent effective at preventing severe cases of COVID-19. The evidence will be discussed during a panel meeting of independent experts on Thursday. Based on the track taken by the vaccine manufactured by Pfizer and BioNTech, the FDA could grant emergency use authorization for the Moderna vaccine as soon as Friday…” (Weixel, 12/15).
Additional coverage of the FDA panel’s findings is available from Financial Times, New York Times, POLITICO, and Roll Call.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.